Retrospective Study
Copyright ©The Author(s) 2015.
World J Otorhinolaryngol. May 28, 2015; 5(2): 65-70
Published online May 28, 2015. doi: 10.5319/wjo.v5.i2.65
Table 1 Distribution of tumor and nodal status
StageT1T2T3T4Total
N0337720
N1555722
N25671230
N3030811
Total1317193483
%15.620.522.941100%
Table 2 Iatrogenic complications of the treatment
TreatmentComplicationsNb%
RadiotherapyRadioepithelitis2328.4
Radiodermatitis78.8
Xerostomia1417.64
Osteoradionecrosis22.9
Cerebral radionecrosis11.2
ChemotherapyPancytopenia1417.64
Renal failure11.2
Table 3 The sites of metastasis
Site of the metastasisn%
Bone33.6
Bone + liver44.8
Orbit11.2
Liver22.4
Brain11.2
Bone + liver + lung11.2
Total1214.40
Table 4 Comparison with some southern Asian nasopharyngeal carcinoma series
Our studyWang et al[20] (a)Goto et al[21] (b)Kawashima et al[22] (c)
Stage T115.6103730
Stage T220.5143018
Stage T322.9201518
Stage T441561835
Overall survival rate97%88%78%87%
Metastasis14%18%11%24%